Paris | France
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech • AgroTech • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Blockchain (& Cryptos) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • Life Science |
| Stages | Seed, Startup, Early Stage, Turnaround, Spinout, Series A, Series B, Series C, Pre-IPO |
| Investing | United States • Canada • Germany • France • Italy • Switzerland • Netherlands • Europe |
| Investment Range | €500,000 - €60,000,000 |
| Assets Under Management | €2,000,000,000 |
About The Fund
Sofinnova Partners is a seasoned venture capital firm founded in 1972 with headquarters in Paris, France. They are dedicated to investing in the life sciences sector, including biopharmaceuticals, biotech, medical devices, and industrial biotechnology. Their focus extends to healthcare and sustainability, supporting visionary entrepreneurs developing breakthrough technologies. With a hands-on approach to sourcing deals, Sofinnova Partners takes a lead role, often acting as the first institutional investor in Seed and Series A financings, but their investment activities range from Seed to Pre-IPO stages, including Early Stage, Turnaround, Spinout, Series B, and Series C rounds. Their minimum and maximum investment sizes are €500,000 and €60,000,000, respectively. Sofinnova Partners is known for their equity expertise and manages over €2 billion in assets. The breadth of their investment is apparent in their diverse fund strategies, including Capital Strategy for early-stage biopharma and medtech startups, MD Start Strategy as a medtech accelerator, Crossover Strategy for later-stage biotech and medtech, Industrial Biotech Strategy focusing on sustainability in agriculture, food, and materials, Telethon Strategy for Italian science, Digital Medicine Strategy at the intersection of biology and data, and Biovelocita Strategy for European biotech startups. They pride themselves on creating companies, evolving their strategies consistently while maintaining a stable vision, embracing experience, agility, and diverse viewpoints to navigate the complex investment environment. In over five decades, they have backed more than 500 companies, creating market leaders and forging lasting partnerships based on trust and transparency. They believe in making investments that meaningfully contribute to society and the planet, supporting a better future through science and opportunity.
What they say:
We invest in life sciences startups with a focus on healthcare and sustainability. We look for visionary entrepreneurs developing breakthrough technologies in biotech, biopharma, medtech, and industrial biotech. We proactively source deals, take a lead role, and are most often the first institutional investor in Seed and Series A financings.
Sofinnova Partners's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
